Screener
Dyne Therapeutics, Inc. DYN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 165,201,329 and 164,950,540 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 16 | 16 |
| Additional paid-in capital | 2,382,172 | 2,367,780 |
| Accumulated other comprehensive loss (gain) | (137) | 475 |
| Accumulated deficit | (1,516,996) | (1,396,142) |
| Total stockholders’ equity | 865,055 | 972,129 |
| Total liabilities and stockholders’ equity | $1,079,950 | $1,186,958 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s total liabilities & equity?
- Dyne Therapeutics, Inc. (DYN) reported total liabilities & equity of $1.08B in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Dyne Therapeutics, Inc.'s total liabilities & equity increased by 49.8% year-over-year, from $721.07M to $1.08B.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total liabilities & equity has grown at a 27.4% compound annual growth rate (CAGR), from $353.33M to $1.19B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Dyne Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude